The Western Norway Mental Health Interface Study on Referral Letters

NCT01374035 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-02-13

No results posted yet for this study

Summary

The main object to this trial is to study the function of referral letters as a mean to coordinate the care process for adult people when referred from Primary Care to Specialised Mental Health Care. The study will explore if and to what degree the quality of these referral letters can be improved, and the potential improvement's impact on defined patient-, professional and organisational related outcomes. According to Medical Research Council guidelines for evaluating complex interventions, a stepwise design with the use of both qualitative and quantitative methods will be used to conduct a controlled intervention study.

Conditions

  • Mental Disorders

Interventions

OTHER

Quality improvement intervention

A complex intervention will be implemented within the group of GPs in the intervention group. It includes participation in defining criteria for good referral letters, information about the correlation between information in the referral letters and outcome, introduction to the guideline, and consecutive feedback on own preformance regarding content of referral letter and outcome for the patient.

Sponsors & Collaborators

  • University of Bergen

    collaborator OTHER
  • KU Leuven

    collaborator OTHER
  • Helse Fonna

    lead OTHER

Principal Investigators

  • Aslak B Aslaksen, MD, PhD · Faculty of Medicine and Dentistery, University of Bergen, Norway

  • Kjell Haug, MD, PhD · Faculty of Medicine and Dentistery, University of Bergen, Norway

  • Kris Vanhaecht, RN, PhD · KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-01
Primary Completion
2016-06-22
Completion
2019-12-13

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374035 on ClinicalTrials.gov